FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company
- The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredients
FMC Corporation Declares Quarterly Dividend
FMC Corporation (NYSE: FMC) announced today that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on January 15, 2026, to shareholders of record as of the close of business on December 31, 2025.
FMC Corporation expands breakthrough pheromone technology to Côte d’Ivoire with registration of Sofero® Frugi pheromone
New pheromone solution helps protect corn crops from devastating fall armyworm